Dr Oxana Polyakova
Over her 20 year career to date, Oxana has worked across multiply therapeutic modalities in both pharma and biotech settings, with significant experience discovering biologics for Oncology indications. Oxana specialises in successfully bringing cell therapies to clinic. Oxana was a founding scientist for cell therapy company GammaDelta Therapeutics before moving to lead discovery at Adaptate Biotherapeutics. Oxana holds a PhD from Moscow State University”.